These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 24560949)
1. Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: structural features and biological implications. Agudelo D; Bourassa P; Bérubé G; Tajmir-Riahi HA Int J Biol Macromol; 2014 May; 66():144-50. PubMed ID: 24560949 [TBL] [Abstract][Full Text] [Related]
2. Encapsulation of antitumor drug Doxorubicin and its analogue by chitosan nanoparticles. Sanyakamdhorn S; Agudelo D; Tajmir-Riahi HA Biomacromolecules; 2013 Feb; 14(2):557-63. PubMed ID: 23305154 [TBL] [Abstract][Full Text] [Related]
3. tRNA binding to antitumor drug doxorubicin and its analogue. Agudelo D; Bourassa P; Beauregard M; Bérubé G; Tajmir-Riahi HA PLoS One; 2013; 8(7):e69248. PubMed ID: 23922696 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic doxorubicin and its derivative bind milk β-lactoglobulin. Agudelo D; Beauregard M; Bérubé G; Tajmir-Riahi HA J Photochem Photobiol B; 2012 Dec; 117():185-92. PubMed ID: 23147200 [TBL] [Abstract][Full Text] [Related]
5. Review on the binding of anticancer drug doxorubicin with DNA and tRNA: Structural models and antitumor activity. Agudelo D; Bourassa P; Bérubé G; Tajmir-Riahi HA J Photochem Photobiol B; 2016 May; 158():274-9. PubMed ID: 26971631 [TBL] [Abstract][Full Text] [Related]
6. Nanopore single-molecule analysis of DNA-doxorubicin interactions. Yao F; Duan J; Wang Y; Zhang Y; Guo Y; Guo H; Kang X Anal Chem; 2015 Jan; 87(1):338-42. PubMed ID: 25493921 [TBL] [Abstract][Full Text] [Related]
7. Probing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albumins. Agudelo D; Bourassa P; Bruneau J; Bérubé G; Asselin E; Tajmir-Riahi HA PLoS One; 2012; 7(8):e43814. PubMed ID: 22937101 [TBL] [Abstract][Full Text] [Related]
8. Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove. Cosman M; Hingerty BE; Luneva N; Amin S; Geacintov NE; Broyde S; Patel DJ Biochemistry; 1996 Jul; 35(30):9850-63. PubMed ID: 8703959 [TBL] [Abstract][Full Text] [Related]
9. Influence of aglycone modifications on the binding of anthracycline drugs to DNA: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG). Gao YG; Wang AH Anticancer Drug Des; 1991 Jul; 6(3):137-49. PubMed ID: 1872945 [TBL] [Abstract][Full Text] [Related]
10. Identification and hydropathic characterization of structural features affecting sequence specificity for doxorubicin intercalation into DNA double-stranded polynucleotides. Kellogg GE; Scarsdale JN; Fornari FA Nucleic Acids Res; 1998 Oct; 26(20):4721-32. PubMed ID: 9753742 [TBL] [Abstract][Full Text] [Related]
11. Applications of chitosan nanoparticles in drug delivery. Tajmir-Riahi HA; Nafisi Sh; Sanyakamdhorn S; Agudelo D; Chanphai P Methods Mol Biol; 2014; 1141():165-84. PubMed ID: 24567139 [TBL] [Abstract][Full Text] [Related]
12. Interaction of antioxidant flavonoids with tRNA: intercalation or external binding and comparison with flavonoid-DNA adducts. Kanakis CD; Tarantilis PA; Polissiou MG; Tajmir-Riahi HA DNA Cell Biol; 2006 Feb; 25(2):116-23. PubMed ID: 16460235 [TBL] [Abstract][Full Text] [Related]
13. Structural modeling for DNA binding to antioxidants resveratrol, genistein and curcumin. N'soukpoé-Kossi CN; Bourassa P; Mandeville JS; Bekale L; Tajmir-Riahi HA J Photochem Photobiol B; 2015 Oct; 151():69-75. PubMed ID: 26188387 [TBL] [Abstract][Full Text] [Related]
14. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent. Baruah H; Wright MW; Bierbach U Biochemistry; 2005 Apr; 44(16):6059-70. PubMed ID: 15835895 [TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2. Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP Biochemistry; 1999 Jul; 38(29):9221-33. PubMed ID: 10413496 [TBL] [Abstract][Full Text] [Related]
16. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery. Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197 [TBL] [Abstract][Full Text] [Related]
17. Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas. Amin M; Badiee A; Jaafari MR Int J Pharm; 2013 Dec; 458(2):324-33. PubMed ID: 24148663 [TBL] [Abstract][Full Text] [Related]
18. Structural analysis of doxorubicin-polymer conjugates. Sanyakamdhorn S; Bekale L; Agudelo D; Tajmir-Riahi HA Colloids Surf B Biointerfaces; 2015 Nov; 135():175-182. PubMed ID: 26255162 [TBL] [Abstract][Full Text] [Related]
19. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018 [TBL] [Abstract][Full Text] [Related]
20. Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D. Alexander CM; Dabrowiak JC; Maye MM Bioconjug Chem; 2012 Oct; 23(10):2061-70. PubMed ID: 23043330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]